首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1439976

全球女性科技市場：洞察、競爭格局、市場預測：2030 年

FemTech - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年02月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計 2024 年至 2030 年期間，全球女性科技市場規模將以 13.52% 的複合年增長率擴大。對女性科技的需求是由數位健康解決方案的增加、人工智慧和虛擬援助的進步、投資和資金的增加、女性對個人健康和衛生意識的提高以及女性傳染病發病率的增加所推動的。政府和其他組織等，從而促進2024-2030 年預測期內女性科技市場的整體成長。

女性科技市場的成長是由多種因素推動的，但關鍵因素之一是對數位科技的需求不斷增長以及個人對這些科技服務的採用。

近年來，所有人口群體對網路和智慧型手機的使用都有所增加。女性科技科技的主要目的是解決世界各地女性的疾病和願望。

由於使用女性科技技術來更好地瞭解和診斷女性面臨的挑戰，因此對女性科技服務有著巨大的需求。女性科技產品市場是由數位科技在不同地方如何用於女性醫療保健所推動的。

此外，政府和其他公共和私人組織增加投資將支持市場需求。此外，隨著近年來女性傳染病的增加，女性科技的需求量很大，女性科技產品和服務可以幫助管理、治療和診斷傳染病。

本報告檢視了全球女性科技市場，並提供了市場概述，包括按類型、應用、最終用戶、地區和進入市場的公司概況劃分的趨勢。

HeraMED
Sera Prognostics
iSono Health, Inc.
Flo Health Inc.
NUVO Inc.
Natural Cycles USA Corp
Athena Feminine Technologies, Inc.
NUROKOR LIMITED
Canopie
Univfy Inc.
Glow Inc.
Clue by Biowink GmbH
Oura Health Oy.
Ava
Laboratory Corporation of America® Holdings
Baymatob Operations Pty. Ltd.
Expectful
Evofem Biosciences, Inc.
March Inc.
Syantra Inc.

第8章KOL瀏覽量

第 9 章專案方法

第 10 章關於 DelveInsight

第 11 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0657

FemTech Market By Type (Devices, Software, And Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness, And Others), By End-User (Hospitals, Fertility Clinics, Diagnostic Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rise of digital healthcare and high figures of chronic and infectious diseases among the female population

The global femtech market is estimated to grow at a CAGR of 13.52% during the forecast period from 2024 to 2030. The demand for femtech is being boosted by a rise in the adoption of digital health solutions, advancement in artificial intelligence and virtual assistance, growth in investments and funding, growing female awareness of personal health and hygiene, rising infectious diseases among women, large investments made by the government and other organizations, among others are thereby contributing to the overall growth of the femtech market during the forecast period from 2024-2030.

FemTech Market Dynamics:

The femtech market is witnessing growth owing to various factors, one of the key factors being the increasing demand for digital technology and the adoption of these technical services by individuals.

All demographic groups have shown growth in internet and smartphone use in recent years. Femtech technology's main objective is to meet the ailments and demands of women all over the world.

There is a significant demand for femtech services as a result of the usage of femtech technologies to better understand and diagnose women's difficulties. The market for femtech products has been driven by how digital technology is being used in different locations to manage women's health.

Additionally, the rising investments by the government and other public and private organizations will fuel market demand. Also, significant demand for femtech has been generated by the rise in infectious diseases among women in recent years as femtech products and services can help manage, treat, and diagnose infectious diseases

Further, the proliferation of mobile apps that keep track of fertility and pregnancy is a key factor boosting the market of femtech. The rising adoption of healthcare strategies that aim to boost the participation of women in clinical studies is also boosting the market of femtech.

In addition, investors are concentrating more on providing funds for programs that benefit women's health and well-being. For instance, Maven Clinic, a teletherapy firm with a focus on women's health, raised USD 90 million in Series E fundraising in November 2022, in the year's largest Femtech deal. Maven has reportedly raised more than USD 300 million in total capital.

Also, in July 2021, the US FDA approved and gave clearance to Natural Cycles to use body temperature data readings collected by smart wearables, such as Oura smart ring, for assessing a woman's fertility and managing pregnancy.

Therefore, the above-mentioned factors are contributing to the growth of the Femtech market during the forecast period from 2024-2030.

However, cybersecurity and privacy concerns, lack of awareness about femtech products and applications in developing nations, and others may restrict the femtech market growth.

The femtech market was significantly impacted during the period of the COVID-19 pandemic. During the initial stage of the pandemic, the sale of femtech suffered a collapse owing to the imposition of strict lockdown rules, and disruption in manufacturing, and supply. Moreover, the outbreak of the pandemic led to the cancellation of outpatient visits for diagnosis, treatment, and management of various reproductive and gynecological ailments. However, with the growing incorporation of telehealth services in the healthcare industry and the availability of various femtech products over e-commerce, the demand for femtech increased suddenly. Thus, owing to the sudden increase, the market players focused on their strategic initiatives to expand their competitive edge in the market, thereby bringing the market of femtech on track. Thus, the aforementioned factors propelled the demand for femtech devices and services during the pandemic and are estimated to do the same in the upcoming years.

FemTech Market Segment Analysis:

Femtech market by Type (Devices, Software, and Services), Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness, and Others), End-User (Hospitals, Fertility Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the femtech market, the reproductive health category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the increasing prevalence of various reproductive ailments and the incorporation of femtech devices and services in the management of reproductive diseases.

For instance, the total fertility rate (TFR) of Filipino women aged 15 to 49 years decreased to 1.7 children per urban woman and 2.2 children per rural woman in 2022 from the previous ten years, according to data released by the Government of the Philippines in November 2022. As a result, the Philippines' fertility rate is currently below the replacement threshold of 2.1 children per woman.

Thus, owing to the rise in female infertility rates, there is a growing need among end users for femtech services, goods, and programs. Thus, it is anticipated to fuel segment growth throughout the forecast period.

Further, the need for femtech solutions for reproductive health is anticipated to expand due to several causes, including the older age of women and environmental variables, which lead to an increase in the number of women having problems before, during, or after pregnancy. Also, owing to a greater emphasis on employment and later marriage, there is currently a trend for women to get pregnant at a later age.

Furthermore, the increase in investment toward reproductive health-related apps and devices, initiatives taken by major governments worldwide, the surging launch of femtech services and devices, and others are also expected to propel the segment growth. For instance, in September 2022, Embr Labs entered into a strategic partnership to launch an innovative women's health product to provide immediate relief from hot flashes during menopause. Embr Wave 2, a sleek wearable that cools or warms at the touch of a button, will now be made available to women in the United Kingdom.

Therefore, the aforementioned factors are predicted to contribute to the increasing demand for this segment thereby driving the growth of the overall femtech market during the forecast period.

North America is expected to dominate the overall FemTech Market:

Among all the regions, North America is estimated to account for the largest share of the global Femtech market in the year 2023. Owing to the factors such as the high prevalence of cancer among women, rising incidence of lifestyle-related disorders, high adoption of technologically advanced products, and others are expected to aid in the growth of the North America femtech market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and growing awareness about femtech products and services among the target population in the region, also helped the market growth in this region.

According to the women's health data that the CDC evaluated in 2022, 12.7% of women in the United States who are 18 or older smoke regularly, 41.8% of women who are 20 or older were obese, and 45.2% of women had hypertension, in 2021. The majority of the people in the region are now inclined towards femtech products and services to overcome infertility because these factors are associated with female infertility. Thus, the above factor is anticipated to fuel the growth of the femtech market in the North America region.

Further, with expanding smartphone penetration and demand for smart health solutions, the healthcare industry in North America has seen rapid digitalization. For instance, the estimates from Mobile Economy North America 2021 indicate that there were 296 million mobile internet users in North America in 2020, and the figure will rise to 323 million by 2025. Thus, the North American femtech market is anticipated to expand as a result of the rising preventative care use, rising health consciousness & awareness, and rising usage of smart wearable devices and mobile health applications for health tracking.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, investments, and others also help in boosting regional product demand. For instance, in August 2022, a United States-based femtech startup scored USD 3.2 million in seed funding in a round led by Thiel Capital with a fitness and wellness pitch that aims to connect women to the hormonal phases of their menstrual cycle for physical and emotional gain.

Also, in March 2021, Clue received the U.S. FDA clearance for the launch of Clue Birth Control-a digital contraceptive built-in Clue application that can predict ovulation statistically by using a tool for birth control. Thus, such strategic steps help to increase the demand for femtech, thereby driving the North America femtech market forward during the forecast period.

FemTech Market Key Players:

Some of the key market players operating in the femtech market include HeraMED, Sera Prognostics, iSono Health, Inc., Flo Health Inc., NUVO Inc., Natural Cycles USA Corp, Athena Feminine Technologies, Inc., NUROKOR LIMITED, Canopie, Univfy Inc., Glow Inc., Clue by Biowink GmbH, Oura Health Oy., Ava, Laboratory Corporation of America® Holdings, Baymatob Operations Pty. Ltd., Expectful, Evofem Biosciences, Inc., March Inc., Syantra Inc., and others.

Recent Developmental Activities in the FemTech Market:

In November 2022, London-based accelerator FemTech Lab launched an innovation space for the FemTech community. The FemTech Hub is the first physical innovation hub dedicated to women's health, especially.

In June 2022, companies in Japan introduced "Femtech" or "Female technology," under which attention is being paid to the health of female employees. This initiative was undertaken by the Ministry of Economy, Trade, and Industry in Japan.

In April 2022, a femtech startup, Conceive, received USD 3.7 million in funding that would be used for its outcomes-oriented fertility solution.

In August 2021, LabCorp, a leading global life sciences company, acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy, and parenting.

Key Takeaways from the FemTech Market Report Study

Market size analysis for current femtech market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global femtech market.

Various opportunities available for the other competitor in the femtech market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current femtech market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for femtech market growth in the coming future?

Target Audience who can be benefited from this FemTech Market Report Study

Femtech products providers

Research organizations and consulting companies

Femtech-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in femtech

Various End-users who want to know more about the femtech market and the latest technological developments in the femtech market.

Frequently Asked Questions for the FemTech Market:

1. What is femtech?

Femtech refers to the tools and programs that support women's health and well-being. Numerous applications involving reproductive systems, fertility challenges, pregnancy, and other women's healthcare issues can make use of these tools and solutions.

2. What is the market for global femtech?

The global femtech market is estimated to grow at a CAGR of 13.52% during the forecast period from 2024 to 2030.

3. What are the drivers for the global femtech market?

The demand for femtech is primarily being heightened by the growing health consciousness amongst the female population, normalizing & proactively addressing women's health issues, increasing disposable income, digital literacy, smartphone penetration, internet connectivity, digital health infrastructure, the growing availability of smart wearable devices, among others, thereby contribute to the overall growth of the femtech market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Femtech market?

5. Which region has the highest share in the femtech market?

North America is expected to dominate the overall femtech market during the forecast period from 2024-2030. Factors such as the rising prevalence of chronic diseases among women, increasing infertility, and growing awareness about femtech products and services among the target population, among others will positively impact the North American femtech market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about women's health also helped the market growth in this region.

1.Femtech Market Report Introduction

2. Femtech Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Femtech Market Key Factors Analysis

4.1. Femtech Market Drivers
- 4.1.1. Rising adoption of digital health solutions
- 4.1.2. Advancements in artificial intelligence and virtual assistance
- 4.1.3. Growing availability of smart wearable devices
4.2. Femtech Market Restraints and Challenges
- 4.2.1. Cybersecurity and privacy concerns
- 4.2.2. Lack of awareness about femtech products and applications in developing nations
4.3. Femtech Market Opportunities
- 4.3.1. The emergence of start-ups focusing on women's health
- 4.3.2. Growth in investments and funding in the femtech industry

5. Femtech Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. Femtech Market Layout

6.1. By Type
- 6.1.1. Devices
- 6.1.2. Software
- 6.1.3. Services
6.2. By Application
- 6.2.1. Reproductive Health
- 6.2.2. Pregnancy & Nursing care
- 6.2.3. Pelvic & Uterine Healthcare
- 6.2.4. General Healthcare & Wellness
- 6.2.5. Others
6.3. By End-User
- 6.3.1. Hospitals
- 6.3.2. Fertility Clinics
- 6.3.3. Diagnostic Centers
- 6.3.4. Others
6.4. By Geography
- 6.4.1. North America Femtech Market Size in USD million (2021-2030)
  - 6.4.1.1. United States Femtech Market Size in USD million (2021-2030)
  - 6.4.1.2. Canada Femtech Market Size in USD million (2021-2030)
  - 6.4.1.3. Mexico Femtech Market Size in USD million (2021-2030)
- 6.4.2. Europe Femtech Market Size in USD million (2021-2030)
  - 6.4.2.1. France Femtech Market Size in USD million (2021-2030)
  - 6.4.2.2. Germany Femtech Market Size in USD million (2021-2030)
  - 6.4.2.3. United Kingdom Femtech Market Size in USD million (2021-2030)
  - 6.4.2.4. Italy Femtech Market Size in USD million (2021-2030)
  - 6.4.2.5. Spain Femtech Market Size in USD million (2021-2030)
  - 6.4.2.6. Rest of Europe Femtech Market Size in USD million (2021-2030)
- 6.4.3. Asia-Pacific Femtech Market Size in USD million (2021-2030)
  - 6.4.3.1. China Femtech Market Size in USD million (2021-2030)
  - 6.4.3.2. Japan Femtech Market Size in USD million (2021-2030)
  - 6.4.3.3. India Femtech Market Size in USD million (2021-2030)
  - 6.4.3.4. Australia Femtech Market Size in USD million (2021-2030)
  - 6.4.3.5. South Korea Femtech Market Size in USD million (2021-2030)
  - 6.4.3.6. Rest of the Asia-Pacific Femtech Market Size in USD million (2021-2030)
- 6.4.4. Rest of the World (RoW) Femtech Market Size in USD million (2021-2030)
  - 6.4.4.1. Middle East Femtech Market Size in USD million (2021-2030)
  - 6.4.4.2. Africa Femtech Market Size in USD million (2021-2030)
  - 6.4.4.3. South America Femtech Market Size in USD million (2021-2030)

7. Femtech Market Company and Product Profiles

7.1. HeraMED
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2. Sera Prognostics
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3. iSono Health, Inc.
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4. Flo Health Inc.
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5. NUVO Inc.
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6. Natural Cycles USA Corp
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7. Athena Feminine Technologies, Inc.
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8. NUROKOR LIMITED
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9. Canopie
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10. Univfy Inc.
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11. Glow Inc.
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12. Clue by Biowink GmbH
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13. Oura Health Oy.
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14. Ava
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
7.15. Laboratory Corporation of America® Holdings
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy
7.16. Baymatob Operations Pty. Ltd.
- 7.16.1. Company Overview
- 7.16.2. Company Snapshot
- 7.16.3. Financial Overview
- 7.16.4. Product Listing
- 7.16.5. Entropy
7.17. Expectful
- 7.17.1. Company Overview
- 7.17.2. Company Snapshot
- 7.17.3. Financial Overview
- 7.17.4. Product Listing
- 7.17.5. Entropy
7.18. Evofem Biosciences, Inc.
- 7.18.1. Company Overview
- 7.18.2. Company Snapshot
- 7.18.3. Financial Overview
- 7.18.4. Product Listing
- 7.18.5. Entropy
7.19. March Inc.
- 7.19.1. Company Overview
- 7.19.2. Company Snapshot
- 7.19.3. Financial Overview
- 7.19.4. Product Listing
- 7.19.5. Entropy
7.20. Syantra Inc.
- 7.20.1. Company Overview
- 7.20.2. Company Snapshot
- 7.20.3. Financial Overview
- 7.20.4. Product Listing
- 7.20.5. Entropy